DE68902212T2 - Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. - Google Patents

Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.

Info

Publication number
DE68902212T2
DE68902212T2 DE8989202588T DE68902212T DE68902212T2 DE 68902212 T2 DE68902212 T2 DE 68902212T2 DE 8989202588 T DE8989202588 T DE 8989202588T DE 68902212 T DE68902212 T DE 68902212T DE 68902212 T2 DE68902212 T2 DE 68902212T2
Authority
DE
Germany
Prior art keywords
prophylaxis
treatment
autoimmune diseases
immunotoxins
auto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989202588T
Other languages
English (en)
Other versions
DE68902212D1 (de
Inventor
Hermanus Antonius Mari Verheul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE68902212D1 publication Critical patent/DE68902212D1/de
Publication of DE68902212T2 publication Critical patent/DE68902212T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A61K47/6827—Ricin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8989202588T 1988-10-21 1989-10-13 Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. Expired - Fee Related DE68902212T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88202349 1988-10-21

Publications (2)

Publication Number Publication Date
DE68902212D1 DE68902212D1 (de) 1992-08-27
DE68902212T2 true DE68902212T2 (de) 1993-05-27

Family

ID=8199870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989202588T Expired - Fee Related DE68902212T2 (de) 1988-10-21 1989-10-13 Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.

Country Status (15)

Country Link
EP (1) EP0365087B1 (de)
JP (1) JP2807506B2 (de)
KR (1) KR0151851B1 (de)
AT (1) ATE78407T1 (de)
AU (1) AU625802B2 (de)
CA (1) CA2000999A1 (de)
DE (1) DE68902212T2 (de)
DK (1) DK523589A (de)
ES (1) ES2051989T3 (de)
FI (1) FI100305B (de)
GR (1) GR3006048T3 (de)
IE (1) IE61831B1 (de)
NZ (1) NZ231095A (de)
PT (1) PT92071B (de)
ZA (1) ZA897895B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012145A1 (en) * 1991-12-19 1993-06-24 Baylor College Of Medicine Pva or peg conjugates of peptides for epitope-specific immunosuppression
WO2000009155A1 (en) 1998-08-11 2000-02-24 Rush-Presbyterian-St.Luke's Medical Center Methods and compositions for preventing anti-gal production in xenograft recipients
KR100346059B1 (ko) * 1999-12-30 2002-07-24 주식회사 효성 폴리에스테르 섬유의 제조방법
ES2370535T3 (es) * 2006-11-23 2011-12-19 Cadila Pharmaceuticals Limited Antagonista de poli-tlr.
WO2018031947A1 (en) 2016-08-12 2018-02-15 Immunowork, Llc Diagnosis, prevention, and/or treatment of autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
DE3513572A1 (de) * 1985-04-16 1986-10-16 Karl Prof. Dr.med. 7302 Ostfildern Theurer Herstellung von praeparaten zur spezifischen beeinflussung der humoralen und zellulaeren immunreaktion
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.

Also Published As

Publication number Publication date
KR900005996A (ko) 1990-05-07
AU4359589A (en) 1990-04-26
GR3006048T3 (de) 1993-06-21
FI895005A0 (fi) 1989-10-20
JP2807506B2 (ja) 1998-10-08
DK523589D0 (da) 1989-10-20
JPH02169523A (ja) 1990-06-29
ES2051989T3 (es) 1994-07-01
ATE78407T1 (de) 1992-08-15
EP0365087A1 (de) 1990-04-25
FI100305B (fi) 1997-11-14
DE68902212D1 (de) 1992-08-27
EP0365087B1 (de) 1992-07-22
PT92071B (pt) 1995-06-30
PT92071A (pt) 1990-04-30
DK523589A (da) 1990-04-22
AU625802B2 (en) 1992-07-16
IE61831B1 (en) 1994-11-30
KR0151851B1 (ko) 1998-10-15
NZ231095A (en) 1992-03-26
CA2000999A1 (en) 1990-04-21
ZA897895B (en) 1990-07-25
IE893324L (en) 1990-04-21

Similar Documents

Publication Publication Date Title
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
TNSN91029A1 (fr) Les analogues du nucleoside de 1,3-oxathiolane
NL970039I1 (nl) Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie.
FR10C0016I2 (fr) Procedes et compositions s'appliquant au traitement de la glomerulonephrite
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE68929388T2 (de) Aus Harn isolierte antikoagulierende Verbindung
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ES2043609T3 (es) Composiciones de interleucina-2.
FI913818A0 (fi) Nytt trombolytiskt aemne.
ES2064613T3 (es) Produccion de agentes citotoxicos.
DE68902212T2 (de) Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.
FR2687681B1 (fr) Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
FR2651435B1 (de)
WO1997025071A3 (en) Immunoconjugate for the treatment of aids
NO891894L (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
DE69122960T2 (de) Verfahren und zubereitungen für die behandlung von verletzungen
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee